Authors: Gisselbaek M et al. Anesthesiology 144(4):1008–1011, April 2026 Summary:This cross-sectional mixed-methods study examines mentorship dynamics in anesthesiology, with a particular focus on gender differences. Using a national survey of over 1,100 members of the American Society of Anesthesiologists along with focus groups, the authors explored how mentorship is accessed, structured, and experienced. The study […]
Read MoreAuthors: Tang J et al. Anesthesiology 144(4):967–977, April 2026 Summary:This comprehensive review addresses the complex and often controversial management of chronic antihypertensive medications in the perioperative period. It synthesizes recent randomized trials, guidelines, and observational data to provide a practical, patient-centered framework for decision-making. A central theme is that there is no one-size-fits-all approach. For […]
Read MoreAuthors: Sugiyama D et al. Anesthesiology 144(4):965–966, April 2026 Summary:This brief clinical report revisits retrograde intubation as a critical rescue airway technique, emphasizing its continued relevance despite the widespread adoption of video laryngoscopy. While modern airway tools have significantly improved visualization, the authors highlight that certain scenarios—such as airway tumors, severe distortion, or bleeding—can render […]
Read MoreAuthors: Riazi S et al. Anesthesiology 144(4):776–783, April 2026 Summary:This article presents a practical, North American–focused framework for evaluating patients at risk for malignant hyperthermia (MH) in the era of widespread genetic testing. As genomic testing becomes more accessible and commonly performed—even as part of routine screening—anesthesiologists are increasingly encountering patients with genetic variants associated […]
Read MoreAuthors: Jansen S et al. Anesthesiology 144(4):913–925, April 2026 Summary:This randomized, double-blind, placebo-controlled study compares the respiratory and analgesic effects of Cebranopadol with Oxycodone in healthy volunteers. Cebranopadol is a novel analgesic that activates both nociceptin (NOP) and µ-opioid (MOP) receptors, raising the possibility of effective pain control with less respiratory depression than traditional opioids. […]
Read More